e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Risk factors and co-morbidities in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The prevalence of co-morbidities and exacerbations in COPD patients in Slovenia
Stanislav Kajba (Celje, Slovenia), Stanislav Kajba
Source:
International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Session:
Risk factors and co-morbidities in asthma and COPD
Session type:
Thematic Poster Session
Number:
1122
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Stanislav Kajba (Celje, Slovenia), Stanislav Kajba. The prevalence of co-morbidities and exacerbations in COPD patients in Slovenia. Eur Respir J 2015; 46: Suppl. 59, 1122
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The frequency of COPD exacerbations is related to the comorbidity profile
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Cardiovascular risk assessment in COPD patients with severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
One-year mortality in COPD patients after severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Survival in COPD patients with hospitalization due to exacerbation
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
COPD exacerbations occur more frequently in women – Data from the Bergmannsheil cohort
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Comorbidities in patients with COPD and their impact on COPD course
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
COPD exacerbation admissions: Analysis of demographics and mortality
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Acute exacerbations of COPD: The influence of comorbidities and chronic medication on mortality and exacerbation rate
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Role of comorbidities on mortality in patients hospitalized for COPD exacerbations
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Gender differences in hospitalized patients with acute exacerbation of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Vitamin D, exacerbations and hospitalizations in COPD patients
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Gender differences of echocardiographic characteristics in patients with acute exacerbation of COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations
Source: International Congress 2014 – COPD markers
Year: 2014
LATE-BREAKING ABSTRACT: No relationship between cardiovascular morbidity and moderate-to-severe exacerbation rates in COPD patients in primary care
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept